MMMarianna Pinheiro Moraes de Moraes

Marianna Pinheiro Moraes de Moraes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marianna Pinheiro Moraes de Moraes has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A diagnostic approach to neurocutaneous syndromes

    by Sofia Mônaco Gama, João Vitor Gerdulli Tamanini, Marianna Pinheiro Moraes de Moraes, Thiago Yoshinaga Tonholo Silva, Fernanda Teresa de Lima, José Luiz Pedroso, Orlando Graziani Povoas Barsottini

    Neurocutaneous syndromes are a group of genetically and phenotypically diverse disorders that primarily affect the skin, central and peripheral nervous systems, and eyes. Classifying neurocutaneous syndromes based on genetic mechanisms often proves impractical in routine clinical settings. This review proposes a practical classification of neurocutaneous syndromes based on their neurological manifestations, including neoplastic lesions, epilepsy, vascular abnormalities, and ataxia. In this narrative review, we examined original articles and reviews that explore neurocutaneous syndromes, published between January 2000 and July 2024. The figures are part of a personal collection of the authors. Early recognition of dermatological and neurological hallmarks can guide diagnosis and prompt timely evaluation and treatment. Therefore, a thorough understanding of neurocutaneous syndromes highlights the importance of integrated diagnostic strategies that combine neurological and dermatological assessments.


  • Open Access

    Chronic levamisole-induced leukoencephalopathy: Uncommon presentation of two cases with adult-onset progressive symptoms

    by João Victor Cabral Correia Férrer, Lara Santos Machado, Luiz José Malta Gaia Ferreira Júnior, Luccas Almeida Andrade, Marianna Pinheiro Moraes de Moraes, José Luiz Pedroso, Orlando Graziani Povoas Barsottini


  • Open Access

    Multiple cerebral cavernomas in linear scleroderma: an unusual association

    by Gabriela Rodrigues Tomaz, Maria Eduarda Slhessarenko Fraife Barreto, Rafael Tuzino Leite Neves Maffei, Renato Barradas Rodrigues, Sebastião Boanerges de Araujo Neto, Marianna Pinheiro Moraes de Moraes, José Luiz Pedroso, Orlando Graziani Povoas Barsottini

    A 30-year-old female patient presented with recurrent right-sided clonic seizures that had started at the age of 4. Concurrently, her parents noted mild hyperpigmentation, dermal atrophy, and alopecia on the left side of her forehead. She was diagnosed with en coup de sabre scleroderma (ECDS), a subtype of linear scleroderma (LS), given the absence of systemic sclerosis symptoms ([Figure 1]). A brain magnetic resonance imaging (MRI) revealed cavernomas and white matter lesions in the left cerebral hemisphere, ipsilateral to the cutaneous lesions ([Figure 2]). Localized facial scleroderma can be associated with neurological complications, as illustrated by our case involving ipsilateral brain cavernomas.[1] [2] [3] This diagnosis is presumptive, as histopathological confirmation of the lesions was not obtained. Differential diagnoses should consider small hemorrhages, potentially secondary to vasculopathy, as suggested by the susceptibility-weighted imaging (SWI) MRI findings.[4] [5] Ayrton Roberto Massaro. Leandro Tavares Lucato. GRT, MESFB, RTNLM, RBR: conceptualization, resources, and writing – original draft; SBAN, supervision; MPMM: supervision and writing – review & editing; JLP, OGPB: supervision. Received: 27 May 2024 Accepted: 21 July 2024 Article published online: 24 September 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil


  • Open Access

    Sjogren's syndrome: a neurological perspective

    by Orlando Grazianni Povoas Barsottini, Marianna Pinheiro Moraes de Moraes, Pedro Henrique Almeida Fraiman, Victor Hugo Rocha Marussi, Alexandre Wagner Silva de Souza, Pedro Braga Neto, Mariana Spitz

    Sjogren's syndrome (SS) is a complex autoimmune disease characterized by lymphocytic infiltration of salivary and lacrimal glands, resulting in sicca symptoms. Additionally, SS presents with neurological manifestations that significantly impact the nervous system. This review aims to provide a comprehensive overview of the neurological aspects of SSj, covering both the peripheral and central nervous system involvement, while emphasizing diagnosis, treatment, and prognosis.


  • Open Access

    Diffuse leptomeningeal enhancement in neurosarcoidosis-related longitudinally extensive myelitis

    by Fabiano Ferreira de Abrantes, Marianna Pinheiro Moraes de Moraes, José Luiz Pedroso, Orlando G. Barsottini

    A 35-year-old man presented with a 1-month history of bilateral lower limb weakness and numbness. On examination, he had paraparesis with lower limbs hyperreflexia, and T5 sensory level. Magnetic resonance imaging (MRI) of the spine revealed a longitudinally extensive myelitis (LETM) with a diffuse leptomeningeal enhancement ([Figure 1]). Thorax computed tomography (CT) disclosed bilateral hilar lymphadenopathy. A transbronchial lymph node fine-needle biopsy revealed noncaseating granulomas. Considering this finding, probable neurosarcoidosis was diagnosed. Leptomeningeal involvement is a remarkable finding in neurosarcoidosis.[1] When central nervous system (CNS) involvement occurs concomitantly with a widespread leptomeningeal enhancement, sarcoidosis should be considered as a possible differential diagnosis.[2] FFA, MPMM: conceptualization, writing – original draft, writing – review & editing; JLP, OGB: conceptualization, writing – review & editing. Received: 18 April 2023 Accepted: 03 May 2023 Article published online: 13 October 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil


  • Immune-mediated ataxias: Guide to clinicians

    by Alex T. Meira, Marianna P.M. de Moraes, Matheus G. Ferreira, Gustavo L. Franklin, Flávio M. Rezende Filho, Hélio A.G. Teive, Orlando G.P. Barsottini, José Luiz Pedroso


  • Open Access

    Conus medullaris syndrome in Vogt-Koyanagi-Harada disease: an unusual presentation

    by Fabiano Ferreira de Abrantes, Marianna Pinheiro Moraes de Moraes, Wardislau Ferreira, Flávio Moura Rezende Filho, José Luiz Pedroso, Orlando Graziani Povoas Barsottini

    A 25-year-old woman presented over one week with subacute flaccid paraparesis, saddle anesthesia and sphincter dysfunction, compatible with conus medullaris syndrome. Lumbar magnetic resonance imaging (MRI) ([Figure 1]) showed spinal cord edema and intense leptomeningeal enhancement. Six months after, she presented with aseptic meningitis and bilateral vision loss. Optical coherence tomography (OCT) showed bilateral exudative retinal detachments ([Figure 2]). Incomplete Vogt-Koyanagi-Harada disease (VKHD) was diagnosed based on the combination of bilateral granulomatous panuveitis and aseptic meningitis.[1] Spinal cord involvement is a frequent manifestation of neurological inflammatory diseases, and VKHD should be considered when typical eye, ear, and skin symptoms are present.[2] [3] FFA: conceptualization, visualization, writing – original draft, and writing – review & editing; MPMM: conceptualization, visualization, writing – original draft, and writing – review & editing; WF: conceptualization, visualization, writing – original draft; FMRF: visualization, writing – original draft; JLP: conceptualization and writing – review & editing; OGPB: conceptualization, visualization, writing – original draft, and writing – review & editing. Received: 26 January 2022 Accepted: 11 February 2022 Article published online: 17 October 2022 © 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

  • Open Access

    Immunosuppressors and immunomodulators in Neurology - Part I: a guide for management of patients underimmunotherapy

    by Fabiano Ferreira Abrantes, Marianna Pinheiro Moraes de Moraes, José Marcos Vieira de Albuquerque Filho, Jéssica Monique Dias Alencar, Alexandre Bussinger Lopes, Wladimir Bocca Vieira de Rezende Pinto, Paulo Victor Sgobbi de Souza, Enedina Maria Lobato de Oliveira, Acary de Souza Bulle de Oliveira, José Luiz Pedroso, et al.

    For patients with autoimmune diseases, the risks and benefits of immunosuppressive or immunomodulatory treatment are a matter of continual concern. Knowledge of the follow-up routine for each drug is crucial, in order to attain better outcomes and avoid new disease activity or occurrence of adverse effects. To achieve control of autoimmune diseases, immunosuppressive and immunomodulatory drugs act on different pathways of the immune response. Knowledge of the mechanisms of action of these drugs and their recommended doses, adverse reactions and risks of infection and malignancy is essential for safe treatment. Each drug has a specific safety profile, and management should be adapted for different circumstances during the treatment. Primary prophylaxis for opportunistic infections and vaccination are indispensable steps during the treatment plan, given that these prevent potential severe infectious complications. General neurologists frequently prescribe immunosuppressive and immunomodulatory drugs, and awareness of the characteristics of each drug is crucial for treatment success. Implementation of a routine before, during and after use of these drugs avoids treatment-related complications and enables superior disease control.


  • Open Access

    X-linked adrenoleukodystrophy presenting as progressive ataxia and pure cerebellar involvement

    by Marianna Pinheiro Moraes de Moraes, Augusto Bragança Reis Rosa, Cristina Saade Jaques, Victor Hugo Rocha Marussi, José Luiz Pedroso, Orlando Graziani Barsottini


  • Open Access

    A clinical approach to hypertrophic pachymeningitis

    by Fabiano Ferreira Abrantes, Marianna Pinheiro Moraes de Moraes, Flávio Moura Rezende Filho, José Luiz Pedroso, Orlando Graziani Povoas Barsottini

    Importance: Hypertrophic pachymeningitis (HP) is a non-usual manifestation of rheumatologic, infectious, and neoplastic diseases. Etiological diagnosis is a challenge, but when made promptly it creates a window of opportunity for treatment, with the possibility of a total reversal of symptoms. Observations: HP is an inflammatory process of the dura mater that can occur as a manifestation of sarcoidosis, granulomatosis with polyangiitis, and IgG4-related disease. The HP case evaluation is extensive and includes central nervous system imaging, cerebrospinal fluid analysis, serology, rheumatologic tests, and systemic survey for other manifestations sites. After systemic investigation, meningeal biopsy might be necessary. Etiology guides HP treatment, and autoimmune disorders are treated with corticosteroids alone or associated with an immunosuppressor. Conclusion: HP is a manifestation of several diseases, and a precise etiological diagnosis is crucial because of the difference among treatments. An extensive investigation of patients with HP helps early diagnosis and correct treatment.